<DOC>
	<DOC>NCT02465008</DOC>
	<brief_summary>The purpose of this study is to determine whether levobupivacaine is effective in the acute postoperative pain treatment in periprosthetic breast augmentation</brief_summary>
	<brief_title>Analgesic Effect of Levobupivacaine in Breast Augmentation</brief_title>
	<detailed_description>One of the most common plastic surgery is breast augmentation using prosthesis ( mammoplasty Surgery with cohesive silicone gel prosthesis insubpectoral plane). Remains challenging management of acute postoperative pain that allows for early discharge of patients. To this end the following objectives are proposed: evaluate the analgesic efficacy of L-Bupivacaine 0.25% vs. Placebo (saline) administered irrigation into the surgical pocket bilaterally intraoperatively.</detailed_description>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Women&gt; 18 and &lt;= 65 years Mammoplasty Surgery with cohesive silicone gel prosthesis in subpectoral plane ASA I and II Informed consent signed Rejection of the patient ASA III or higher Other conditions that warrant their inclusion as medically indicated (eg psychiatric illness). Allergy to NSAIDs, local anesthetics and / or morphine Patients treated for chronic pain Placement of drains for surgical needs</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>postoperative</keyword>
	<keyword>Patient-reported</keyword>
</DOC>